Skip To Content
JEWISH. INDEPENDENT. NONPROFIT.
Fast Forward

House Passes Bill Promoting Anti-Semitism Envoy To Ambassador

(JTA) — The U.S. House of Representatives passed legislation that upgrades to ambassador level the position of special envoy to monitor and combat anti-Semitism at the State Department.

The Special Envoy to Monitor and Combat Anti-Semitism Act was authored by Rep. Chris Smith, R-N.J., who helped write the 2004 law that created the monitor post.

Lawmakers and Jewish communal organizations have chafed at the Trump administration’s failure to name someone to the anti-Semitism monitor post since Donald Trump became president, citing a perceived spike in anti-Semitism worldwide.

Under the legislation, the anti-Semitism monitor would be the primary adviser to the U.S. government in monitoring and combating anti-Semitism and would not have extraneous duties. The president must nominate a candidate for the position within 90 days of the legislation becoming law.

“Tragically, anti-Semitism is on the rise across the globe,” Rep. Peter Roskam, R-Ill., co-chair of the Bipartisan Taskforce for Combating anti-Semitism, said in a statement following the legislation’s passage in the House. “The bipartisan Special Envoy to Monitor and Combat Anti-Semitism Act reinforces our nation’s leadership in fighting this scourge by elevating the position of Special Envoy to Monitor and Combat Anti-Semitism to the rank of Ambassador and ensuring that the Special Envoy is solely focused on this important task.

“History teaches us that anti-Semitism is defeated only when it is confronted directly. The Special Envoy to Monitor and Combat Anti-Semitism Act is a strong step forward as Congress seeks to defeat global anti-Semitism.”

The other co-chairs of the Bipartisan Congressional Task Force for Combating Anti-Semitism who cosponsored the bill are Reps. Chris Smith, R-N.J.; Nita Lowey, D-N.Y.; Ileana Ros-Lehtinen, R-Fla.; Eliot Engel, D-N.Y.; Kay Granger, R-Texas; Ted Deutch. D-Fla; and Marc Veasey, D-Texas.

The legislation still must pass the Senate Foreign Relations Committee and the full Senate.

I hope you appreciated this article. Before you go, I’d like to ask you to please support the Forward’s award-winning, nonprofit journalism during this critical time.

Now more than ever, American Jews need independent news they can trust, with reporting driven by truth, not ideology. We serve you, not any ideological agenda.

At a time when other newsrooms are closing or cutting back, the Forward has removed its paywall and invested additional resources to report on the ground from Israel and around the U.S. on the impact of the war, rising antisemitism and the protests on college campuses.

Readers like you make it all possible. Support our work by becoming a Forward Member and connect with our journalism and your community.

Make a gift of any size and become a Forward member today. You’ll support our mission to tell the American Jewish story fully and fairly. 

— Rachel Fishman Feddersen, Publisher and CEO

Join our mission to tell the Jewish story fully and fairly.

Republish This Story

Please read before republishing

We’re happy to make this story available to republish for free, unless it originated with JTA, Haaretz or another publication (as indicated on the article) and as long as you follow our guidelines. You must credit the Forward, retain our pixel and preserve our canonical link in Google search.  See our full guidelines for more information, and this guide for detail about canonical URLs.

To republish, copy the HTML by clicking on the yellow button to the right; it includes our tracking pixel, all paragraph styles and hyperlinks, the author byline and credit to the Forward. It does not include images; to avoid copyright violations, you must add them manually, following our guidelines. Please email us at editorial@forward.com, subject line “republish,” with any questions or to let us know what stories you’re picking up.

We don't support Internet Explorer

Please use Chrome, Safari, Firefox, or Edge to view this site.

Exit mobile version